|
NEWS
----- Press Release -----
Upperton
Launches Contract Particle Technology Services.
Upperton
announces that it is to launch a new contract service,
providing a specialised spray drying service to the
pharmaceutical industry.
23rd
September 2002
Nottingham,
UK: Upperton today announced that it is to launch a
contract particle technology service to the pharmaceutical
industry. This new service is aimed at established pharmaceutical
companies that are interested in assessing the use of
spray drying at an early stage in the development of
their pharmaceutical formulations.
The
need for such a service has become apparent in recent
years as spray drying becomes an important technology
for the pharmaceutical industry. Its suitability for
the formulation of a wide range of active ingredients
has led to a rapid growth in its use. Such formulation
applications include targetting and microencapsulation
of both therapeutic and diagnostic agents. The growth
in pharmaceutical spray drying is driven by a number
of advantages over competing technologies (eg. freeze-drying
and micronisation), including lower processing costs,
ease of scale-up and particularly speed, with its ability
to transform solutions into highly defined particles
in seconds.
Upperton
is looking to use its considerable experience to assess
the suitability of spray drying as a formulation tool
at an early stage in product development. This experience
will be applied to a customer's product allowing a quick
assessment of the ability of spray drying to meet the
desired product profile. The spray-dried product will
be characterised to agreed specifications and returned
along with all manufacturing and analytical data to
the customer for evaluation.
Upperton's
Founding Director, Dr Richard Johnson, added "This service
allows customers to assess the potential of spray drying
at a small scale without the need for capital investment.
Add to this the experience that Upperton possesses in
this field and it is clear that we offer the simplest
and most cost effective route to the successful development
of spray-dried pharmaceuticals"
-----
End -----
|
